$1.45 Billion is the total value of NEA Management Company, LLC's 53 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 17.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COUR | Sell | COURSERA INC | $148,236,699 | -21.0% | 12,867,769 | -18.9% | 10.25% | -2.9% |
| ARCELLX INC | $146,201,522 | -0.5% | 4,745,262 | 0.0% | 10.11% | +22.3% | ||
| VRNA | VERONA PHARMA PLCsponsered ads | $112,141,840 | -23.2% | 5,584,753 | 0.0% | 7.75% | -5.5% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $100,553,557 | +23.2% | 4,186,243 | 0.0% | 6.95% | +51.5% | |
| IONQ INC | $89,881,198 | +78.3% | 14,614,829 | 0.0% | 6.21% | +119.3% | ||
| NET | Sell | CLOUDFLARE INC | $77,026,597 | -9.1% | 1,249,215 | -33.3% | 5.32% | +11.8% |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $71,818,636 | +11.3% | 1,587,854 | 0.0% | 4.96% | +36.9% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $59,923,001 | +2.4% | 7,692,298 | 0.0% | 4.14% | +25.9% | |
| BERKSHIRE GREY INC | $52,692,572 | +128.5% | 38,183,023 | 0.0% | 3.64% | +181.0% | ||
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $51,913,615 | -63.7% | 2,909,956 | -40.7% | 3.59% | -55.3% |
| BHG | BRIGHT HEALTH GROUP INC | $48,059,242 | -66.1% | 218,153,623 | 0.0% | 3.32% | -58.3% | |
| SVRA | SAVARA INC | $47,068,965 | +25.8% | 24,137,931 | 0.0% | 3.25% | +54.7% | |
| GERN | Buy | GERON CORP | $46,324,808 | +17.3% | 21,347,838 | +30.8% | 3.20% | +44.3% |
| AUPH | AURINIA PHARMACEUTICALS INC | $43,509,381 | +153.7% | 3,969,834 | 0.0% | 3.01% | +212.0% | |
| DM | DESKTOP METAL INC | $33,117,532 | +69.1% | 14,398,927 | 0.0% | 2.29% | +108.1% | |
| RPHM | RENEO PHARMACEUTICALS INC | $28,617,254 | +156.7% | 4,785,494 | 0.0% | 1.98% | +215.5% | |
| ALLK | ALLAKOS INC | $27,355,307 | -47.1% | 6,147,260 | 0.0% | 1.89% | -35.0% | |
| ZEROFOX HLDGS INC | $26,380,029 | -67.4% | 18,068,513 | 0.0% | 1.82% | -59.9% | ||
| CVRX | CVRX INC | $22,093,452 | -49.2% | 2,370,542 | 0.0% | 1.53% | -37.5% | |
| TRVI | Sell | TREVI THERAPEUTICS INC | $21,035,196 | -4.2% | 11,370,376 | -0.0% | 1.45% | +17.8% |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $18,616,958 | -25.3% | 17,079,779 | 0.0% | 1.29% | -8.1% | |
| BUZZFEED INC | $17,327,298 | +63.9% | 15,333,892 | 0.0% | 1.20% | +101.7% | ||
| NEXTNAV INC | $16,623,987 | -30.7% | 8,189,156 | 0.0% | 1.15% | -14.8% | ||
| CTIC | CTI BIOPHARMA CORP | $15,479,869 | -30.1% | 3,685,683 | 0.0% | 1.07% | -14.1% | |
| INZY | INOZYME PHARMA INC | $13,967,958 | +445.7% | 2,437,689 | 0.0% | 0.97% | +570.8% | |
| CELC | CELCUITY INC | $12,812,510 | -26.8% | 1,250,001 | 0.0% | 0.89% | -10.0% | |
| NKTX | NKARTA INC | $12,669,173 | -40.7% | 3,568,781 | 0.0% | 0.88% | -27.1% | |
| XFOR | X4 PHARMACEUTICALS INC | $10,211,010 | -12.4% | 11,736,793 | 0.0% | 0.71% | +7.8% | |
| TUYA | TUYA INCsponsered ads | $9,326,470 | -1.0% | 4,934,640 | 0.0% | 0.64% | +21.7% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $6,889,154 | -10.9% | 1,713,720 | 0.0% | 0.48% | +9.7% | |
| Buy | MINERVA SURGICAL INC | $6,803,040 | +204.5% | 34,437,052 | +244.4% | 0.47% | +273.0% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $6,518,151 | +5.0% | 3,448,757 | 0.0% | 0.45% | +29.2% | |
| GLYC | Sell | GLYCOMIMETICS INC | $6,003,194 | -77.9% | 4,764,440 | -46.9% | 0.42% | -72.8% |
| LXRX | LEXICON PHARMACEUTICALS INC | $5,788,955 | +27.2% | 2,382,286 | 0.0% | 0.40% | +56.2% | |
| IVA | INVENTIVA SAads | $4,993,269 | -28.7% | 1,462,586 | 0.0% | 0.34% | -12.4% | |
| Buy | SENTI BIOSCIENCES INC | $4,921,682 | -7.9% | 4,700,385 | +6.2% | 0.34% | +13.3% | |
| ACRIVON THERAPEUTICS INC | $4,889,985 | +10.2% | 481,677 | 0.0% | 0.34% | +35.7% | ||
| GOSS | GOSSAMER BIO INC | $4,368,932 | -41.9% | 3,467,406 | 0.0% | 0.30% | -28.6% | |
| AFMD | AFFIMED NV | $3,300,389 | -39.9% | 4,426,488 | 0.0% | 0.23% | -26.0% | |
| SYBX | SYNLOGIC INC | $2,672,690 | -16.8% | 4,228,940 | 0.0% | 0.18% | +2.2% | |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $1,602,425 | -40.5% | 2,294,095 | -23.4% | 0.11% | -26.5% |
| RGLS | REGULUS THERAPEUTICS INC | $1,224,734 | -38.1% | 1,445,114 | 0.0% | 0.08% | -23.4% | |
| ADXN | Buy | ADDEX THERAPEUTICS LTDsponsored ads | $1,112,792 | +881.1% | 5,648,690 | +423.0% | 0.08% | +1183.3% |
| New | EARGO INC | $1,057,680 | – | 226,000 | +100.0% | 0.07% | – | |
| Sell | AIRSPAN NETWORKS HOLDINGS INC | $941,419 | -48.0% | 1,359,842 | -1.6% | 0.06% | -36.3% | |
| New | MARKER THERAPEUTICS INC | $760,714 | – | 1,071,428 | +100.0% | 0.05% | – | |
| UP | Buy | WHEELS UP EXPERIENCE INC | $681,563 | -37.6% | 1,108,371 | +4.4% | 0.05% | -23.0% |
| Sell | FISCALNOTE HOLDINGS INC | $576,166 | -94.0% | 307,344 | -81.9% | 0.04% | -92.6% | |
| OBSV | OBSEVA SA | $499,935 | -24.8% | 4,586,563 | 0.0% | 0.04% | -5.4% | |
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $82,159 | -61.3% | 452,167 | 0.0% | 0.01% | -50.0% | |
| PANW | New | PALO ALTO NETWORKS INC | $15,580 | – | 78 | +100.0% | 0.00% | – |
| AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $67 | +9.8% | 69,928 | 0.0% | 0.00% | – | ||
| AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $30 | -72.7% | 69,928 | 0.0% | 0.00% | – | ||
| Exit | AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $0 | – | -69,928 | -100.0% | 0.00% | – | |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -8,533,072 | -100.0% | -0.12% | – |
| EAR | Exit | EARGO INC | $0 | – | -4,520,198 | -100.0% | -0.15% | – |
| MRKR | Exit | MARKER THERAPEUTICS INC | $0 | – | -10,714,285 | -100.0% | -0.16% | – |
| Exit | XERIS BIOPHARMA HOLDINGS INC | $0 | – | -3,246,785 | -100.0% | -0.24% | – | |
| BILL | Exit | BILL COM HLDGS INC | $0 | – | -66,070 | -100.0% | -0.38% | – |
| OYST | Exit | OYSTER PT PHARMA INC | $0 | – | -5,925,287 | -100.0% | -3.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.